» Articles » PMID: 36416119

The Fatty Acid Imbalance of Cystic Fibrosis Exists at Birth Independent of Feeding in Pig and Ferret Models

Overview
Journal Clin Sci (Lond)
Date 2022 Nov 23
PMID 36416119
Authors
Affiliations
Soon will be listed here.
Abstract

Persons with cystic fibrosis (CF) exhibit a unique alteration of fatty acid composition, marked especially among polyunsaturates by relative deficiency of linoleic acid and excess of Mead acid. Relative deficiency of docosahexaenoic acid is variably found. However, the initial development of these abnormalities is not understood. We examined fatty acid composition in young CF ferrets and pigs, finding abnormalities from the day of birth onward including relative deficiency of linoleic acid in both species. Fatty acid composition abnormalities were present in both liver and serum phospholipids of newborn CF piglets even prior to feeding, including reduced linoleic acid and increased Mead acid. Serum fatty acid composition evolved over the first weeks of life in both non-CF and CF ferrets, though differences between CF and non-CF persisted. Although red blood cell phospholipid fatty acid composition was normal in newborn animals, it became perturbed in juvenile CF ferrets including relative deficiencies of linoleic and docosahexaenoic acids and excess of Mead acid. In summary, fatty acid composition abnormalities in CF pigs and ferrets exist from a young age including at birth independent of feeding and overlap extensively with the abnormalities found in humans with CF. That the abnormalities exist prior to feeding implies that dietary measures alone will not address the mechanisms of imbalance.

Citing Articles

Unbalanced long-chain fatty acid beta-oxidation in newborns with cystic fibrosis and congenital hypothyroidism.

Pinnaro C, Ryckman K, Uc A, Norris A Mol Genet Metab Rep. 2025; 42:101182.

PMID: 39816991 PMC: 11732690. DOI: 10.1016/j.ymgmr.2024.101182.


Fatty acid abnormalities in cystic fibrosis-the missing link for a cure?.

Drzymala-Czyz S, Walkowiak J, Colombo C, Alicandro G, Storrosten O, Kolsgaard M iScience. 2024; 27(11):111153.

PMID: 39620135 PMC: 11607544. DOI: 10.1016/j.isci.2024.111153.


Dysregulation of the Arachidonic Acid Pathway in Cystic Fibrosis: Implications for Chronic Inflammation and Disease Progression.

DOrazio S, Mattoscio D Pharmaceuticals (Basel). 2024; 17(9).

PMID: 39338347 PMC: 11434829. DOI: 10.3390/ph17091185.


Special Issue: "Recent Advances in Ion Channels and Ion Channelopathies".

Hryciw D Int J Mol Sci. 2024; 25(7).

PMID: 38612410 PMC: 11012210. DOI: 10.3390/ijms25073598.


Changes in nutrition and growth status in young children in the first 12 weeks of ivacaftor therapy.

Tindall A, Bass R, Maqbool A, Stallings V J Cyst Fibros. 2023; 22(6):989-995.

PMID: 37438197 PMC: 10776802. DOI: 10.1016/j.jcf.2023.04.010.


References
1.
Sun X, Sui H, Fisher J, Yan Z, Liu X, Cho H . Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. J Clin Invest. 2010; 120(9):3149-60. PMC: 2929732. DOI: 10.1172/JCI43052. View

2.
Van Biervliet S, Vanbillemont G, Van Biervliet J, Declercq D, Robberecht E, Christophe A . Relation between fatty acid composition and clinical status or genotype in cystic fibrosis patients. Ann Nutr Metab. 2008; 51(6):541-9. DOI: 10.1159/000114208. View

3.
Silversand C, Haux C . Improved high-performance liquid chromatographic method for the separation and quantification of lipid classes: application to fish lipids. J Chromatogr B Biomed Sci Appl. 1998; 703(1-2):7-14. DOI: 10.1016/s0378-4347(97)00385-x. View

4.
Dif F, Wu Y, Burgel P, Ollero M, Leduc D, Aarbiou J . Critical role of cytosolic phospholipase A2{alpha} in bronchial mucus hypersecretion in CFTR-deficient mice. Eur Respir J. 2010; 36(5):1120-30. DOI: 10.1183/09031936.00183409. View

5.
Lepage G, Roy C . Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res. 1986; 27(1):114-20. View